Skip to main content
L

Lepu Medical Technology (Beijing) Co.,Ltd. — Investor Relations & Filings

Ticker · 300003 LEI · 3003007FXUYE3WNDDO39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,400 across all filing types
Latest filing 2026-04-22 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300003

About Lepu Medical Technology (Beijing) Co.,Ltd.

https://www.lepumedical.com

Lepu Medical Technology (Beijing) Co.,Ltd. specializes in the development, manufacture, and distribution of medical devices and equipment, primarily focused on cardiovascular disease management. The company provides a comprehensive range of products spanning the entire patient care cycle, including prevention, screening, diagnosis, treatment, and rehabilitation. Its core portfolio features interventional cardiology solutions such as coronary stents, bioresorbable scaffolds, and PTCA balloon catheters. Additionally, the company offers structural heart disease devices, cardiac rhythm management systems, and anesthesia products. Lepu Medical also maintains a significant presence in the in vitro diagnostics (IVD) sector and produces advanced medical electronic equipment, including ECG machines and patient monitors. By leveraging integrated R&D and manufacturing capabilities, the company serves healthcare providers worldwide with innovative medical solutions.

Recent filings

Filing Released Lang Actions
公司章程（2026年4月）
Governance Information Classification · 1% confidence The document is clearly the full Articles of Association (公司章程) of 乐普（北京）医疗器械股份有限公司, detailing the company’s internal rules, organizational structure, shareholder rights, board and committee provisions, and governance procedures. It is not an announcement or summary but the primary governance charter, fitting the Governance Information definition (CGR).
2026-04-22 Chinese
关于开展外汇套期保值业务的公告
Regulatory Filings Classification · 1% confidence The document is a public announcement by 乐普医疗 of its board’s approval to undertake foreign exchange hedging business, detailing transaction limits, purposes, and authorization procedures. It does not present financial results (so it is not an earnings release, interim or annual report), nor is it a notice of share issuance, dividend, management change, or M&A. It is also not a report publication announcement. Therefore, it falls under the general ‘Regulatory Filings’ (RNS) category as a miscellaneous regulatory announcement.
2026-04-22 Chinese
2025年度内部控制评价报告
Audit Report / Information Classification · 1% confidence The document is a standalone “2025年度内部控制评价报告” (Internal Control Evaluation Report) issued by the company’s board and audit committee. It does not contain full audited financial statements like an Annual Report (10-K) nor is it an earnings release or interim (IR). Instead, it is a specialized audit‐related report on the effectiveness of internal controls, matching the definition of a standalone audit report under our taxonomy. Therefore, it is classified as an Audit Report / Information (AR).
2026-04-22 Chinese
董事会审计委员会对会计师事务所2025年度履职情况评估及履行监督职责情况的报告
Audit Report / Information Classification · 1% confidence The document is a standalone report issued by the company’s Board Audit Committee evaluating and supervising the external audit firm’s performance for the 2025 fiscal year. It is not the full annual report, not a notice of filing, and not a management or financial results announcement. It specifically relates to audit oversight and evaluation, fitting the definition of an Audit Report / Information filing.
2026-04-22 Chinese
关于举行2025年度暨2026年一季度网上业绩说明会的公告
Regulatory Filings Classification · 1% confidence The document is a brief announcement (486 characters) by the company notifying investors that the 2025 annual report and 2026 Q1 report have already been published on the regulator’s website and announcing the date/time and logistics for an upcoming online performance briefing (“网上业绩说明会”). It does not itself contain financial results or slides, nor is it a transcript of a call; rather, it is a miscellaneous regulatory notice about an event and referencing report publication. There is no dedicated category for an earnings‐call invitation, so by elimination (and given its short “report published” notice nature) it falls into the general Regulatory Filings fallback category (RNS).
2026-04-22 Chinese
关于董事会换届选举的公告
Board/Management Information Classification · 1% confidence The document is an announcement (“公告”) of the board of directors’ renewal election, detailing the nomination of new non-independent and independent director candidates and describing procedures for the forthcoming shareholder vote. This fits the definition of a Board/Management Information filing, which covers announcements of changes in the company’s board of directors or senior management.
2026-04-22 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.